NMDA Receptor Agonists
| Cat. No. | Product Name / Activity |
|---|---|
| 0216 | L-Cysteinesulfinic acid |
| NMDA and mGlu agonist | |
| 3406 | GLYX 13 |
| NMDA partial agonist; acts at the glycine site | |
| 0281 | (R)-(+)-HA-966 |
| NMDA partial agonist/antagonist; acts at glycine site | |
| 0285 | Ibotenic acid |
| NMDA agonist; also non selective mGlu agonist | |
| 0114 | NMDA |
| Selective NMDA agonist | |
| 0225 | Quinolinic acid |
| Endogenous NMDA agonist and transmitter candidate | |
| 0312 | (RS)-(Tetrazol-5-yl)glycine |
| Highly potent NMDA agonist |
Highlights around 500 products for ion channel research.
Request copyRequest PDF
Our Neurodegeneration guide highlights over 275 products for neurodegeneration research.
Request copyRequest PDF
Our Pain guide highlights over 280 products for Pain research.
Request copyRequest PDFWritten by Alan Palmer
Our Alzheimer's disease poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease.
Request copyDownload PDFWritten by P. Skolnich et al
Our Depression poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder.
Request copyDownload PDF
Written by Alsa Pitkänen and Xavier Ekolle Ndode-Ekane, this poster summarizes current knowledge about how epilepsy develops.
Request copyDownload PDF
Our Huntington's Disease (HD) poster summarizes the medium spiny neuron intracellular signaling pathways implicated in the pathology of HD.
Request copyDownload PDFWritten by Clea Warburton and Zafar Bashir
Our Learning and Memory poster gives an overview of the cellular mechanisms underlying recognition memory and its links to long-term depression.
Request copyDownload PDFWritten by Grant D. Nicol and Michael R. Vasko
Our Peripheral Sensitization poster gives a summary of the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization.
Request copyDownload PDFWritten by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDFWritten by Justin M. Saunders and Javier González-Maeso
Our Schizophrenia poster highlights the targets and pathways representing the most promising strategies to pursue for novel drug development.
Request copyDownload PDF